Treosulfan-based reduced intensity conditioning in HLA-haploidentical transplantation using PTCY as GVHD prophylaxis in high-risk MDS/AML of the elderly

被引:0
|
作者
Fraccaroli, Alessia [1 ]
Prevalsek, Dusan [1 ]
Haebe, Sarah [1 ]
Buecklein, Veit [1 ]
Schulz, Christoph [1 ]
Drolle, Heidrun [1 ]
Fritsch, Susanne [1 ]
Ledderose, Georg [1 ]
Tischer, Johanna [1 ]
机构
[1] LMU, Univ Hosp Munich, Munich, Germany
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P116
引用
收藏
页码:217 / 217
页数:1
相关论文
共 50 条
  • [1] Treosulfan-versus melphalan-based reduced intensity conditioning in HLA-haploidentical transplantation using PTCY as GvHD prophylaxis in high-risk MDS /AML of the elderly: a matched-pair analysis
    Fraccaroli, A.
    Haebe, S.
    Drolle, H.
    Buecklein, V.
    Schulz, C.
    Prevalsek, D.
    Tischer, J.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 98 - 98
  • [2] Treosulfan- Versus Melphalan-Based Reduced Intensity Conditioning in Sequential HLA-Haploidentical Transplantation Using Ptcy As GvHD Prophylaxis in High-Risk MDS /AML of the Elderly: A Matched-Pair Analysis
    Fraccaroli, Alessia
    Haebe, Sarah
    Drolle, Heidrun
    Stauffer, Elena
    Buecklein, Veit
    Prevalsek, Dusan
    von Bergwelt, Michael
    Tischer, Johanna
    [J]. BLOOD, 2020, 136
  • [3] Favorable Outcome of Sequential HLA-Haploidentical Transplantation Using Ptcy As GvHD Prophylaxis in High Risk AML and MDS of the Elderly
    Fraccaroli, Alessia
    Prevalsek, Dusan
    Haebe, Sarah Elena
    Buecklein, Veit
    Schulz, Christoph
    Drolle, Heidrun
    Fritsch, Susanne
    Ledderose, Georg
    von Bergwelt, Michael
    Hiddemann, Wolfgang
    Tischer, Johanna
    [J]. BLOOD, 2018, 132
  • [4] Sequential HLA-haploidentical transplantation utilizing post-transplantation cyclophosphamide for GvHD prophylaxis in high-risk and relapsed/refractory AML/MDS
    Fraccaroli, Alessia
    Prevalsek, Dusan
    Fritsch, Susanne
    Haebe, Sarah
    Buecklein, Veit
    Schulz, Christoph
    Hubmann, Max
    Stemmler, Hans-Joachim
    Ledderose, Georg
    Hausmann, Andreas
    Schmid, Christoph
    Tischer, Johanna
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : 1524 - 1531
  • [5] Treosulfan-Versus Melphalan-Based Reduced Intensity Conditioning in HLA-Haploidentical Transplantation for Patients ≥ 50 Years with Advanced MDS/AML
    Fraccaroli, Alessia
    Stauffer, Elena
    Haebe, Sarah
    Prevalsek, Dusan
    Weiss, Lena
    Dorman, Klara
    Drolle, Heidrun
    von Bergwelt-Baildon, Michael
    Stemmler, Hans-Joachim
    Herold, Tobias
    Tischer, Johanna
    [J]. CANCERS, 2024, 16 (16)
  • [6] Treosulfan-Based Reduced-Toxicity Conditioning for Elderly Patients with High-Risk Myelodysplastic and Myeloproliferative Disease for Allogeneic Hematopoietic Stem Cell Transplantation
    Neagoie, Adela Maria
    Wais, Verena
    Gantner, Andrea
    Schnell, Jacqueline
    Strauss, Katrin
    Weidt, Conrad
    Dohner, Hartmut
    Bunjes, Donald Werner
    Sala, Elisa
    [J]. BLOOD, 2023, 142
  • [7] Outcome of patients with high-risk AML and MDS after reduced-intensity conditioning stem cell transplantation
    Uzunov, M.
    Wittnebel, S.
    Boccaccio, C.
    Bourhis, J. H.
    [J]. BONE MARROW TRANSPLANTATION, 2008, 41 : S209 - S209
  • [8] Transplantation-associated microangiopathy (TAM) in recipients of HLA-haploidentical hematopoietic stem cell transplants using PTCY, CNI and MMF for GvHD prophylaxis
    Fraccaroli, Alessia
    Stauffer, Elena
    Prevalsek, Dusan
    Drolle, Heidrun
    Schoenermarck, Ulf
    von Bergwelt, Michael
    Tischer, Johanna
    [J]. INTERNIST, 2022, 63 (SUPPL 3): : 340 - 340
  • [9] Transplantation-Associated Microangiopathy (TAM) in Recipients of HLA-Haploidentical Hematopoietic Stem Cell Transplants Using Ptcy, CNI and MMF for GvHD Prophylaxis
    Fraccaroli, Alessia
    Prevalsek, Dusan
    Haebe, Sarah
    Bucklein, Veit
    Drolle, Heidrun
    Schoenermarck, Ulf
    Hiddemann, Wolfgang
    von Bergwelt, Michael
    Tischer, Johanna
    [J]. BLOOD, 2019, 134
  • [10] T-cell replete allografting using sequential conditioning regimen in HLA-matched versus HLA-haploidentical transplantation in older high-risk MDS and AML patients: Results of a matched pair analysis
    Fraccaroli, Alessia
    Prevalsek, Dusan
    Haebe, Sarah
    Schulz, Christoph
    Drolle, Heidrun
    Fritsch, Susanne
    Ledderose, Georg
    Tischer, Johanna
    [J]. BONE MARROW TRANSPLANTATION, 2018, 53 : 292 - 293